Showing results (131-140 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|October 1, 1996
Drug-induced delirium. Incidence, management and preventionG L Carter, A H Dawson, R Lopert
Drug Safety|September 1, 1996
Anticonvulsant-induced psychiatric disorders. The role of forced normalisationM R Trimble
Drug Safety|September 1, 1996
ACE inhibitors and the kidney. A risk-benefit assessmentG Navis, H J Faber, D de Zeeuw, et al.
Drug Safety|May 20, 2008
Safety of green tea extracts : a systematic review by the US PharmacopeiaDandapantula N Sarma, Marilyn L Barrett, Mary L Chavez, et al.
Drug Safety|May 20, 2008
Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerabilityBernard Bannwarth
Drug Safety|April 22, 2008
Surveillance of suspected adverse reactions to natural health products: the case of propolisFrancesca Menniti-Ippolito, Gabriela Mazzanti, Annabella Vitalone, et al.
Drug Safety|April 22, 2008
Cosmetovigilance: the 'beautiful' riskUgo Moretti, Giampaolo Velo
Drug Safety|March 28, 2008
Dysglycaemias and fluoroquinolonesRoshan J Lewis, John F Mohr
Drug Safety|March 28, 2008
Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in PortugalMaria T Herdeiro, Jorge Polónia, Juan J Gestal-Otero, et al.
Drug Safety|April 3, 2025
IQ DILI Consensus Opinion: Best Practices for Rechallenge Following Suspected Drug-Induced Liver Injury in Clinical TrialsKlaudia Steplewski, Lucy Walker, Nefeteria Coffee, et al.
Pageof 308